Vaishali Pharma wins tenders for supply to Vanuatu & Samoa Islands

Vaishali Pharma Limited has been awarded two tenders for the supply of surgical & pharma products to Vanuatu Islands and for the supply of surgical products to Samoa Islands. 

Vanuatu is a South Pacific Ocean nation made up of roughly 80 islands. The demand for healthcare products is increasing in Vanuatu Islands due to the increasing rates of non-communicable diseases (NCDs), death, and illness affecting the health of people. 

Samoa Islands is located in the Polynesian region of South Pacific Ocean, about halfway between Hawaii and New Zealand. The market of surgical products is increasing in Samoa Islands due to the increasing rates of premature mortality caused due to Alzheimer, blood pressure, and chronic heart diseases, etc. 

On the financial front, for the quarter ending December 2020, the company’s standalone revenue grew by 109 per cent to Rs 21.61 crore. Its EBITDA was up by 212 per cent and the EBITDA margin stood at 13.9 per cent. The net profit for the quarter increased 603 per cent to Rs 1.72 crore. 

Vaishali Pharma is amongst the leading players in the supply of pharma products-bulk drugs/APIs, formulations, surgical products, veterinary supplements, herbal & nutraceutical products, etc. It has over 150+ formulation brands marketed in multiple countries; of which, the dossier is in CTD format along with its respective bioequivalence. The company has built a robust pipeline of around 250 dossiers. 

In the early morning session on Monday, its stock was trading 2.9 per cent higher at Rs 38.70 from its previous close of Rs 37.60 on NSE.